News
Timothy A. Price
- February 26, 2024
Sales Performance
- Smith & Nephew PLC is set to announce its 2023 results on Tuesday.
- Revenue is expected to increase to $5.53 billion from $5.21 billion in the previous year.
- Fourth-quarter revenue is projected to rise to $1.44 billion.
Underlying Revenue Growth
- Estimated underlying revenue growth of 6.9% is anticipated.
- This marks a significant improvement from the 4.7% growth seen in 2022.
Trading Profit
- Predicted trading profit increase to $966 million from $901 million.
- Trading profit margin expected at 17.4%, slightly below guidance of 17.5%.
Stock Performance
- Shares have decreased by 6.4% over the past year but have risen by 5.4% since the beginning of 2023.
Key Points to Monitor
- Net dividend yield for 2023 is expected to decrease slightly, according to Citi analysts.
- Sector volume growth likely to benefit from positive order backlog and increasing number of active patients undergoing procedures early in life.
- Stable pricing anticipated for this year, supported by better pricing discipline, innovation, and cost reduction programs.
Outlook
- Short-term outlook suggests another year of above-average growth in the global orthopedic market for 2024.
Contact Michael Susin
PREVIOUS POST
President's Day Home Buying Surge
NEXT POST
Ryanair's Boeing Woes
Our Latest News
Malaysia's Inflation Cools in November
Malaysia's inflation rate cooled in November as core products prices grew at a slower pace. Food and beverage prices decreased while other sectors saw stable or...
Iceland's Prime Minister and Women Demand Equality
Iceland's Prime Minister, Katrin Jakobsdottir, joins nationwide strike for gender equality and an end to violence against women.
Serabi Gold Reports Higher Profit and Increased Gold Production
Serabi Gold announces higher pretax profit and increased gold production in the first half of the year. The company remains optimistic about future growth and e...